Trial intelligence / Profile preview

DIADS: Sertraline for Depression in Alzheimer's Disease

NCT00009191Phase 4Completed

Sponsor
Johns Hopkins University
Start
Nov 2005
Primary completion
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by Johns Hopkins University. Started Nov 2005; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00009191.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00009191.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call